Biotechnology companies face monumental challenges – from containing R&D costs to managing sales and marketing to compliance with regulatory bodies.
Biotech startups often operate with just a few employees, all of whom tend to pull double duty, both in the lab and front office. With that in mind, BioNJ has produced a free document available to companies (not just New Jersey-based ) interested in streamlining the often time-consuming process of negotiating clinical trial agreements.
The project is a collaboration between BioNJ, Rutgers University and the law firm of Sheppard Mullin Richter & Hampton LLP, and has been reviewed and endorsed by Rutgers University and Rowan University.
“Our objective is to free up much needed resources and time for research, accelerating the development of state-of-the-art therapeutics and diagnostics emerging from research discoveries,” said BioNJ President Debbie Hart.
Biotech companies interested in obtaining a Clinical Trials Master Service Agreement template may email BioNJ at [email protected].